Literature DB >> 27287871

Glioma-mediated microglial activation promotes glioma proliferation and migration: roles of Na+/H+ exchanger isoform 1.

Wen Zhu1, Karen E Carney1, Victoria M Pigott1, Lindsay M Falgoust1, Paul A Clark2,3, John S Kuo2,3, Dandan Sun4,5.   

Abstract

Microglia play important roles in extracellular matrix remodeling, tumor invasion, angiogenesis, and suppression of adaptive immunity in glioma. Na(+)/H(+) exchanger isoform 1 (NHE1) regulates microglial activation and migration. However, little is known about the roles of NHE1 in intratumoral microglial activation and microglia-glioma interactions. Our study revealed up-regulation of NHE1 protein expression in both glioma cells and tumor-associated Iba1(+) microglia in glioma xenografts and glioblastoma multiforme microarrays. Moreover, we observed positive correlation of NHE1 expression with Iba1 intensity in microglia/macrophages. Glioma cells, via conditioned medium or non-contact glioma-microglia co-cultures, concurrently upregulated microglial expression of NHE1 protein and other microglial activation markers (iNOS, arginase-1, TGF-β, IL-6, IL-10 and the matrix metalloproteinases MT1-MMP and MMP9). Interestingly, glioma-stimulated microglia reciprocally enhanced glioma proliferation and migration. Most importantly, inhibition of microglial NHE1 activity via small interfering RNA (siRNA) knockdown or the potent NHE1-specific inhibitor HOE642 significantly attenuated microglial activation and abolished microglia-stimulated glioma migration and proliferation. Taken together, our findings provide the first evidence that NHE1 function plays an important role in glioma-microglia interactions, enhancing glioma proliferation and invasion by stimulating microglial release of soluble factors. NHE1 upregulation is a novel marker of the glioma-associated microglial activation phenotype. Inhibition of NHE1 represents a novel glioma therapeutic strategy by targeting tumor-induced microglial activation.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27287871      PMCID: PMC5008247          DOI: 10.1093/carcin/bgw068

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  54 in total

Review 1.  Na(+)/H(+) exchanger NHE1 as plasma membrane scaffold in the assembly of signaling complexes.

Authors:  Martin Baumgartner; Hitesh Patel; Diane L Barber
Journal:  Am J Physiol Cell Physiol       Date:  2004-10       Impact factor: 4.249

Review 2.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

Review 3.  Tumor metastasis: molecular insights and evolving paradigms.

Authors:  Scott Valastyan; Robert A Weinberg
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

Review 4.  Physiology, pharmacology and pathophysiology of the pH regulatory transport proteins NHE1 and NBCn1: similarities, differences, and implications for cancer therapy.

Authors:  E Boedtkjer; L Bunch; S F Pedersen
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

5.  Glioma-associated microglial MMP9 expression is upregulated by TLR2 signaling and sensitive to minocycline.

Authors:  Feng Hu; Min-Chi Ku; Darko Markovic; Omar Dildar a Dzaye; Seija Lehnardt; Michael Synowitz; Susanne A Wolf; Helmut Kettenmann
Journal:  Int J Cancer       Date:  2014-05-09       Impact factor: 7.396

6.  MK-2206, a novel allosteric inhibitor of Akt, synergizes with gefitinib against malignant glioma via modulating both autophagy and apoptosis.

Authors:  Yan Cheng; Yi Zhang; Li Zhang; Xingcong Ren; Kathryn J Huber-Keener; Xiaoyuan Liu; Lei Zhou; Jason Liao; Heike Keihack; Li Yan; Eric Rubin; Jin-Ming Yang
Journal:  Mol Cancer Ther       Date:  2011-11-04       Impact factor: 6.261

7.  NHE1 mediates MDA-MB-231 cells invasion through the regulation of MT1-MMP.

Authors:  Yani Lin; Guoqiang Chang; Jian Wang; Weina Jin; Lihong Wang; Huawen Li; Li Ma; Qinghua Li; Tianxiang Pang
Journal:  Exp Cell Res       Date:  2011-06-06       Impact factor: 3.905

8.  Fas engagement increases expression of interleukin-6 in human glioma cells.

Authors:  Chulhee Choi; G Yancey Gillespie; Nicholas J Van Wagoner; Etty N Benveniste
Journal:  J Neurooncol       Date:  2002-01       Impact factor: 4.130

Review 9.  CSF-1 receptor signaling in myeloid cells.

Authors:  E Richard Stanley; Violeta Chitu
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-06-02       Impact factor: 10.005

10.  Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis.

Authors:  Mamatha Bangalore Nijaguna; Vikas Patil; Serge Urbach; Shivayogi D Shwetha; Kotha Sravani; Alangar S Hegde; Bangalore A Chandramouli; Arimappamagan Arivazhagan; Philippe Marin; Vani Santosh; Kumaravel Somasundaram
Journal:  J Biol Chem       Date:  2015-08-05       Impact factor: 5.157

View more
  30 in total

Review 1.  Microglial interactions with the neurovascular system in physiology and pathology.

Authors:  Xiaoliang Zhao; Ukpong B Eyo; Madhuvika Murugan; Long-Jun Wu
Journal:  Dev Neurobiol       Date:  2018-02-01       Impact factor: 3.964

Review 2.  Glioblastoma niches: from the concept to the phenotypical reality.

Authors:  Davide Schiffer; Marta Mellai; Enrica Bovio; Ilaria Bisogno; Cristina Casalone; Laura Annovazzi
Journal:  Neurol Sci       Date:  2018-05-08       Impact factor: 3.307

3.  Synthetic analogues of the montanine-type alkaloids with activity against apoptosis-resistant cancer cells.

Authors:  Karthik Govindaraju; Aude Ingels; Md Nabiul Hasan; Dandan Sun; Veronique Mathieu; Marco Masi; Antonio Evidente; Alexander Kornienko
Journal:  Bioorg Med Chem Lett       Date:  2018-02-02       Impact factor: 2.823

4.  The Identification of Macrophage-enriched Glycoproteins Using Glycoproteomics.

Authors:  Jelani C Zarif; Weiming Yang; James R Hernandez; Hui Zhang; Kenneth J Pienta
Journal:  Mol Cell Proteomics       Date:  2017-03-27       Impact factor: 5.911

Review 5.  Reactive Astrocytes in Glioblastoma Multiforme.

Authors:  Xiudong Guan; Md Nabiul Hasan; Shelly Maniar; Wang Jia; Dandan Sun
Journal:  Mol Neurobiol       Date:  2018-01-23       Impact factor: 5.590

Review 6.  The neuropathological basis to the functional role of microglia/macrophages in gliomas.

Authors:  Davide Schiffer; Marta Mellai; Enrica Bovio; Laura Annovazzi
Journal:  Neurol Sci       Date:  2017-06-07       Impact factor: 3.307

7.  Pathogenesis of peritumoral hyperexcitability in an immunocompetent CRISPR-based glioblastoma model.

Authors:  Asante Hatcher; Kwanha Yu; Jochen Meyer; Isamu Aiba; Benjamin Deneen; Jeffrey L Noebels
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

Review 8.  Roles of glial ion transporters in brain diseases.

Authors:  Shanshan Song; Lanxin Luo; Baoshan Sun; Dandan Sun
Journal:  Glia       Date:  2019-08-16       Impact factor: 7.452

9.  Comparison of [18F]Fluoroethyltyrosine PET and Sodium MRI in Cerebral Gliomas: a Pilot Study.

Authors:  Aliaksandra Shymanskaya; Wieland A Worthoff; Gabriele Stoffels; Johannes Lindemeyer; Bernd Neumaier; Philipp Lohmann; Norbert Galldiks; Karl-Josef Langen; N Jon Shah
Journal:  Mol Imaging Biol       Date:  2020-02       Impact factor: 3.488

10.  Quantitative sodium imaging and gliomas: a feasibility study.

Authors:  Lucidio P Nunes Neto; Guillaume Madelin; Terlika Pandit Sood; Chih-Chun Wu; Douglas Kondziolka; Dimitris Placantonakis; John G Golfinos; Andrew Chi; Rajan Jain
Journal:  Neuroradiology       Date:  2018-06-03       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.